PREOPERATIVE CHEMOTHERAPY WITH CISPLATIN, 100 MG M(2) VERSUS 50 MG/M(2) IN STAGE IIIA (N2) NONSMALL CELL LUNG-CANCER (NSCLC) - A RANDOMIZEDSTUDY BY THE SPANISH LUNG-CANCER GROUP/
C. Martin et al., PREOPERATIVE CHEMOTHERAPY WITH CISPLATIN, 100 MG M(2) VERSUS 50 MG/M(2) IN STAGE IIIA (N2) NONSMALL CELL LUNG-CANCER (NSCLC) - A RANDOMIZEDSTUDY BY THE SPANISH LUNG-CANCER GROUP/, European journal of cancer, 34, 1998, pp. 138-138